| Chelsea Lynne Reighard, MD | |
|
8 Medical Park Dr, Asheville, NC 28803-2493 | |
| (828) 258-1586 | |
| Not Available |
| Full Name | Chelsea Lynne Reighard |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 6 Years |
| Location | 8 Medical Park Dr, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043706070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301506649 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asheville Eye Associates Pllc | 2466405808 | 24 |
News Archive
Omeros Corporation today announced that it has obtained an exclusive license to compounds from Asubio Pharma Co., Ltd. for use in its PDE7 program, which is focused on the treatment of movement disorders.
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
The findings, which come from a Journal of Diabetes analysis of 11,515 men and 13,569 women in China, indicate that nutrition in early life may play a role in the development of subsequent metabolic disorders.
Jean-François Côté, a researcher at the Montreal Clinical Research Institute and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer.
A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
› Verified 7 days ago
| Entity Name | Asheville Eye Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295799823 PECOS PAC ID: 2466405808 Enrollment ID: O20050225000580 |
News Archive
Omeros Corporation today announced that it has obtained an exclusive license to compounds from Asubio Pharma Co., Ltd. for use in its PDE7 program, which is focused on the treatment of movement disorders.
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
The findings, which come from a Journal of Diabetes analysis of 11,515 men and 13,569 women in China, indicate that nutrition in early life may play a role in the development of subsequent metabolic disorders.
Jean-François Côté, a researcher at the Montreal Clinical Research Institute and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer.
A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Lynne Reighard, MD 8 Medical Park Dr, Asheville, NC 28803-2493 Ph: (828) 258-1586 | Chelsea Lynne Reighard, MD 8 Medical Park Dr, Asheville, NC 28803-2493 Ph: (828) 258-1586 |
News Archive
Omeros Corporation today announced that it has obtained an exclusive license to compounds from Asubio Pharma Co., Ltd. for use in its PDE7 program, which is focused on the treatment of movement disorders.
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
The findings, which come from a Journal of Diabetes analysis of 11,515 men and 13,569 women in China, indicate that nutrition in early life may play a role in the development of subsequent metabolic disorders.
Jean-François Côté, a researcher at the Montreal Clinical Research Institute and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer.
A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
› Verified 7 days ago
Dr. Ernest C Skidmore Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5833 | |
Dr. Jason Edward Karo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Hendersonville Rd Ste 302, Asheville, NC 28803 Phone: 828-252-6922 Fax: 828-252-6989 | |
Thomas Mock Brosnan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Centrepark Drive, Ste A, Asheville, NC 28805 Phone: 828-254-9693 Fax: 828-254-9695 | |
Walter Copley Mclean Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 21 Medical Park Dr, Asheville, NC 28803 Phone: 828-255-8978 Fax: 828-251-9150 | |
Edward Kenneth Isbey Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Park Dr, Asheville, NC 28803 Phone: 828-258-1586 Fax: 828-258-6161 | |
Dr. Benjamin David Wilson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Town Square Blvd Ste 110, Asheville, NC 28803 Phone: 828-651-8662 |